⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

March 28, 2024Open Access

Figure S6 from MARCH2, a Novel Oncogene-regulated SNAIL E3 Ligase, Suppresses Triple-negative Breast Cancer Metastases

Koichi Ito Ibuki Harada Criseyda Martinez Katsutoshi Sato Eunjee Lee Elisa Port Jessica H. Byerly Anupma Nayak Ekta Tripathi Jun Zhu Hanna Y. Irie

View Full Paper

Ask AI

Bookmark

Share

Abstract

Figure S6 shows prognostic significance of MARCH2 levels in different cancer types

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ito et al. (2024) studied this question.

synapsesocial.com/papers/68e71feab6db643587699c1a https://doi.org/10.1158/2767-9764.25499265.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S5 from MARCH2, a Novel Oncogene-regulated SNAIL E3 Ligase, Suppresses Triple-negative Breast Cancer Metastases2024
2Figure S7 from MARCH2, a Novel Oncogene-regulated SNAIL E3 Ligase, Suppresses Triple-negative Breast Cancer Metastases2024
3Figure S8 from MARCH2, a Novel Oncogene-regulated SNAIL E3 Ligase, Suppresses Triple-negative Breast Cancer Metastases2024
4Figure S1 from MARCH2, a Novel Oncogene-regulated SNAIL E3 Ligase, Suppresses Triple-negative Breast Cancer Metastases2024
5Figure S4 from MARCH2, a Novel Oncogene-regulated SNAIL E3 Ligase, Suppresses Triple-negative Breast Cancer Metastases2024